Cargando…

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma

Detalles Bibliográficos
Autores principales:	Lurain, Kathryn, Ramaswami, Ramya, Marshall, Vickie, Castro, Elena M. Cornejo, Labo, Nazzarena, Miley, Wendell, Moore, Kyle, Roshan, Romin, Mangusan, Ralph, Jaffe, Elaine S., Pittaluga, Stefania, Wang, Hao-Wei, Roth, Mark, Filie, Armando C., Uldrick, Thomas S., Whitby, Denise, Yarchoan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316280/ https://www.ncbi.nlm.nih.gov/pubmed/36546459 http://dx.doi.org/10.3324/haematol.2022.281472

Ejemplares similares

Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
por: Nalwoga, Angela, et al.
Publicado: (2021)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020)

Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

Comparison of Epstein–Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3–89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States
por: Knights, Sheena M, et al.
Publicado: (2023)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs
por: Sabourin, Katherine R., et al.
Publicado: (2020)

Kaposi’s sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands
por: Nalwoga, Angela, et al.
Publicado: (2019)

Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome
por: Labo, Nazzarena, et al.
Publicado: (2014)

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination
por: Sallah, Neneh, et al.
Publicado: (2018)

Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
por: Lam, Alex K., et al.
Publicado: (2023)

Current epidemiology of KSHV infection in American men who have sex with men
por: Labo, Nazzarena, et al.
Publicado: (2010)

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions
por: Marshall, Vickie A., et al.
Publicado: (2018)

Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis
por: Ramaswami, Ramya, et al.
Publicado: (2023)

T-cell responses to KSHV infection: a systematic approach
por: Roshan, Romin, et al.
Publicado: (2017)

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
por: Yarchoan, R, et al.
Publicado: (2009)

Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
por: Wakeham, Katie, et al.
Publicado: (2011)

Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study
por: Wakeham, Katie, et al.
Publicado: (2015)

Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
por: Wakeham, Katie, et al.
Publicado: (2013)

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2021)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections
por: Sallah, Neneh, et al.
Publicado: (2020)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

827. High KSHV Seroprevalence Among MSM with HIV Associated with Oral Intercourse and Methamphetamine Use in the Southern United States
por: Knights, Sheena, et al.
Publicado: (2021)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Variation in KSHV prevalence between geographically proximate locations in Uganda
por: Nalwoga, Angela, et al.
Publicado: (2020)

Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
por: Marshall, Vickie, et al.
Publicado: (2012)

Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008
por: Sabourin, Katherine R., et al.
Publicado: (2023)

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
por: Burbelo, Peter D, et al.
Publicado: (2010)

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
por: Polizzotto, Mark N, et al.
Publicado: (2012)

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s Sarcoma development
por: Dai, Lu, et al.
Publicado: (2018)

Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda
por: Nalwoga, Angela, et al.
Publicado: (2015)

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma
por: Uldrick, Thomas S., et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling
por: Choi, Hong Seok, et al.
Publicado: (2015)

Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
por: Shrestha, Prabha, et al.
Publicado: (2023)

Kaposi sarcoma herpesvirus pathogenesis
por: Mariggiò, Giuseppe, et al.
Publicado: (2017)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer
por: Odeny, Thomas A, et al.
Publicado: (2022)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature
por: Viollet, Coralie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_34uv4ueuaf3lrhokh2vgvlsd9l